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SUMMARY
The pro-inﬂammatory cytokine tumour necrosis factor alpha (TNF-a) is associated with malaria virulence (disease
severity) in both rodents and humans. We are interested in whether parasite genetic diversity inﬂuences TNF-mediated
eﬀects onmalaria virulence. Here, primary infections with genetically distinctPlasmodium chabaudi chabaudi (P.c.c.) clones
varied in the virulence and cytokine responses induced in female C57BL/6 mice. Even when parasitaemia was controlled
for, a greater day 7 TNF-a response was induced by infection with more virulent P.c.c. clones. Since many functions of
TNF-a are exerted through TNF receptor 1 (TNFR1), a TNFR-1 fusion protein (TNFR-Ig) was used to investigate
whether TNFR1 blockade eliminated clone virulence diﬀerences. We found that TNFR-1 blockade ameliorated the
weight loss but not the anaemia induced by malaria infection, regardless of P.c.c. clone. We show that distinct P.c.c.
infections induced signiﬁcantly diﬀerent plasma interferon gamma (IFN-c), interleukin 6 (IL-6) and interleukin 10
(IL-10) levels. Our results demonstrate that regardless of P.c.c. genotype, blocking TNFR1 signalling protected against
weight loss, but had negligible eﬀects on both anaemia and asexual parasite kinetics. Thus, during P.c.c. infection, TNF-a
is a key mediator of weight loss, independent of parasite load and across parasite genotypes.
Key words: malaria, Plasmodium chabaudi, tumour necrosis factor-a (TNF-a), parasite genotype, virulence,
immunopathology, disease severity, cachexia.
INTRODUCTION
Malaria represents an enormous global health
problem, causing immense morbidity and mortality
(deﬁned here as virulence) worldwide (Snow et al.
2005). Malaria infection causes a wide spectrum
of virulence, resulting in an estimated 2 million
deaths each year (Alles, 1998). We are interested
in understanding the causes of this variation in
virulence. Both ﬁeld and rodent studies have shown
that while some virulence is directly linked to para-
site load (Langhorne et al. 1998; Mackinnon and
Read, 2004), some is immunopathological, arising
as a result of the host’s immune response to the
parasite (Dodoo et al. 2002; Torre et al. 2002). The
‘cytokine theory’ of malaria, for example, hypoth-
esizes that cytokines contribute to disease (Clark et al.
2004), and the potent pro-inﬂammatory cytokine
tumour necrosis factor alpha (TNF-a) has been
shown to have dual roles in malaria infection:
inhibiting in vivo parasite growth and controlling
infection on the one hand (Langhorne et al. 1989;
Stevenson et al. 1995; Jacobs et al. 1996; Sam et al.
1999; Li and Langhorne, 2000), while causing
immune-mediated disease on the other (Grau et al.
1987; Clark and Chaudhri, 1988a, b ; Kern et al.
1992).
We are particularly interested in whether the
host immune response contributes to the diﬀerent
virulence outcomes induced by genetically dis-
tinct P.c.c. infections. Studies using Plasmodium
chabaudi chabaudi (P.c.c.), the immunologically best-
characterized rodent model of malaria, have focused
largely on a single clone: AS (Langhorne et al. 1989;
Stevenson et al. 1995; Jacobs et al. 1996; Sam et al.
1999; Li and Langhorne, 2000). However, primary
infections by other P.c.c. clones have been shown to
induce a spectrum of virulence phenotypes in a given
inbred mouse strain, supporting a role for parasite
strain in virulence determination (Mackinnon and
Read, 1999a, b ; Ferguson et al. 2003). Strain-speciﬁc
variation in malaria virulence during human P. falci-
parum infections has also been reported (Gravenor
et al. 1995; Chotivanich et al. 2000). Because high
serum TNF-a concentrations are associated with
severe infection (Grau et al. 1989; Molyneux et al.
1991, 1993) and malaria parasites directly stimulate
the production of TNF-a from macrophages (Bate
et al. 1992; Bate et al. 1988, 1989, 1992; Bate and
Kwiatkowski, 1994), we hypothesized that parasite
genetic diﬀerences in induction of systemic TNF-a
* Corresponding author. Tel : +44 131 650 5484. Fax:
+44 131 650 6564. E-mail : grainne.long@ed.ac.uk
673
Parasitology (2006), 133, 673–684. f 2006 Cambridge University Press
doi:10.1017/S003118200600117X Printed in the United Kingdom
may contribute to clone diﬀerences in virulence. For
example, distinct P.c.c. clones may achieve high
virulence by (i) growing to high parasite densities
in the host, (ii) inducing a large TNF-a response,
or (iii) through a combination of these factors.
Ignoring the role parasite genotype plays in
determining immune-mediated virulence may lead
to conclusions which are parasite strain- or clone-
speciﬁc. In the ﬁeld of Leishmania, the role mouse
strain played in disease outcome was the initial focus
and led to conﬂicting data until it was recognized
that parasite genotype could help to explain re-
ported diﬀerences in disease outcome (Kebaier et al.
2001; Ritter et al. 2004). For example, infection with
a range of L. major strains in BALB/c mice resulted
in distinct immune responses and a spectrum of
virulence, from asymptomatic to visceral leishman-
iasis (Kebaier et al. 2001). In addition, the anaemia
induced during rodent Trypanosoma infections
(Naessens et al. 2005) and the outcome of toxo-
plasmosis in rodent models (Mordue et al. 2001)
have been shown to depend on the immune response
induced by the particular host-parasite combination.
For malaria, numerous studies have shown that
mouse strains vary in their ability to control and
clear primary infections (Li et al. 2001). However,
immunological analysis of the role of the parasite
strain in determining the outcome of malaria has
largely been overlooked, with the majority of rodent
studies focusing on a single parasite strain or clone
from a given Plasmodium species.
In the present study, we took two approaches
to understand the role TNF-a plays in response to
infection with distinct malaria genotypes. First, we
investigated whether the level of virulence induced
by the genetically distinct P.c.c. clones correlated
with a speciﬁc host cytokine response. We found
that more virulent clones induced a greater plasma
TNF-a response. To directly test whether the
induction of a large TNF-a response is the reason
some clones are more virulent, we then blocked
TNF-a signalling by administering a soluble form
of the TNF Receptor 1 (TNFR-Ig) and followed
in vivo virulence, parasite dynamics and cytokine
responses during distinct P.c.c. infections. We found
that blocking TNFR-1 signalling protected against
weight loss, but the level of protection did not diﬀer
among clones.
MATERIALS AND METHODS
Mice and parasites
Plasmodium chabaudi chabaudi (P.c.c.) clones were
originally derived from thicket rat isolates and
cryopreserved (Walliker et al. 1971). Clones were
stored as frozen stabilities, with subscript codes
denoting their exact clonal history. In both exper-
iments we used the following clones; CW640, AS11915,
BC200 and AJ4762 (herein referred to as CW, AS, BC
and AJ). These 4 genetically distinct P.c.c. clones
were selected based on the range of virulence they
induce in C57BL/6 female mice; clones BC and AJ
are virulent and clones AS and CW substantially less
virulent in terms of weight and red blood cell loss
(Mackinnon and Read, 1999a). Clone diﬀerences in
virulence are maintained across mouse strain
(de Roode et al. 2005; Mackinnon et al. 2002). In
both Experiments 1 and 2, hosts were 6 to 8-week-
old female inbred C57BL/6 mice (Harlan, UK
or bred at animal facilities of the University of
Edinburgh, respectively).Mice were housed in ﬁlter-
top cages, maintained in a 12 h : 12 h light-dark cycle,
fed 41B maintenance diet (Harlan, UK) and their
drinking water was supplemented with 0.05% para-
amino benzoic acid (Jacobs, 1964).
Experimental design, parasite inoculation
and in vivo antibody treatment
Infections were initiated with an i.p. injection of
0.1 ml of inoculum containing 106 red blood cells
(RBCs) parasitized by one of the above 4 malaria
clones. The inoculum was prepared from parasite
donor mice through the dilution of infected blood
in calf serum solution (50% Ringer’s solution (27 mM
KCL, 27 mM CaCl2, 0
.15 M NaCl), 50% heat-
inactivated calf-serum, 20 units heparin/ml mouse
blood). Control mice received a 0.1 ml inoculum of
106 naı¨ve RBCs and were subject to the same treat-
ment regimes as experimental mice.
In Exp. 1, we investigated whether clone diﬀer-
ences in malaria virulence could be explained by
diﬀerences in plasma levels of TNF-a, interleukin
[IL]-6, IL-12p70, IL-10 or interferon [IFN]-c in
unmanipulated hosts on days 2, 5 or 7 post-infection
(p.i.). Three mice per parasite clone were sacriﬁced
at each time-point and plasma was collected for
cytokine measurement. These time-points have
previously been associated with protective or
pathological cytokine responses in P.c.c. AS infec-
tions (Li et al. 1999, 2003; Sam and Stevenson,
1999; Su and Stevenson, 2002).
In Exp. 2, the eﬀect of blocking TNFR1 signalling
on infection dynamics was investigated via the
administration of a soluble TNF Receptor. Soluble
TNF Receptor 1 (herein referred to as TNFR-Ig)
has been shown to bind and eﬃciently inhibit mouse
TNF-a activity in vivo (Ashkenazi et al. 1991) and
was kindly provided by the Therapeutic Anti-
body Centre, University of Oxford (Oxford, UK).
Malaria infections were initiated as in Exp. 1 and
mice were intra-muscularly injected with 75 mg
of either TNFR-Ig or an isotype control human
puriﬁed IgG1 (Sigma) dissolved in sterile PBS
(Gibco) on days 5, 6, 7 and 8 p.i. (5 mice per clone,
per antibody treatment). Data from control mice
in Exp. 2 replicated results from Exp. 1. TNFR-Ig
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treatment was started on day 5 p.i. in order to
minimize interference with the anti-parasitic eﬀect
of TNF-a early in infection (Langhorne et al.
1989; Stevenson and Tam, 1993).
Monitoring parasitaemia and virulence
Thin blood smears were made daily from tail blood
and, after Giemsa staining, the proportions of RBCs
parasitized (parasitaemia) were counted micro-
scopically using r1000 magniﬁcation. RBCs were
counted until 20 parasites were detected in 2 or
more separate ﬁelds of vision. This method has
been shown mathematically to eliminate the bias
in estimates of parasitaemias which arises for stat-
istical reasons when parasites are rare on smears
(Crooks, 2004). RBC densities were obtained by ﬂow
cytometery (Beckmann Coulter) from a 1 : 40 000
dilution of a 2 ml sample of tail blood in Isoton
solution every day p.i. in Exp. 1 and on days 0, 2, 4,
days 5–12 and then every 2 days until day 21 p.i. in
Exp. 2, when mice were sacriﬁced. Mouse weights
were recorded to the nearest 0.1 g on those days
p.i. indicated above.
Plasma cytokine detection
In Exp. 1, blood from individual mice was col-
lected into heparinized tubes on the day of sacriﬁce
(days 2, 5 or 7 p.i.). In Exp. 2, 50 ml of tail-blood from
individual mice was collected into 50 ml heparin
(Sigma) on day 7 p.i. Blood was kept on ice and
centrifuged at 500 g for 10 min (4 xC) to obtain
plasma, which was frozen at x20 xC until the day
of assay. Plasma levels of the cytokines TNF-a,
IL-12p70, IL-6, IFN-c and IL-10 were detected
using a ﬂow cytometric cytokine bead array (BDTM
CBA Array), with slight modiﬁcations from the
manufacturer’s instructions (BD Biosciences).
Brieﬂy, 50 ml of plasma sample or standard were
incubated in ﬂat-bottomed 96-well plates (Costar1)
with 25 ml of cytokine capture bead mixture (anti-
cytokine-coated microspheres) in darkness, with
shaking for 1 h at room temperature. Wells were
then washed with 200 ml of wash buﬀer (1rPBS
solution) and plates were spun at 200 g for 5 min.
Samples and standards were incubated with 25 ml
of PE detection reagent (phycoerythrin-conjugated
anti-mouse cytokine antibodies) in darkness for 1 h.
Wells were then washed and beads re-suspended
in 200 ml of wash buﬀer and analysed on FACsArray
analyser (BDTM Biosciences).
Statistical analysis
Traits fell into 3 categories: virulence traits (live-
weight and anaemia), parasite traits (parasitaemia)
and immunological traits (plasma cytokines). The
minimum live-weight and RBC counts reached
over the course of infection were used as virulence
parameters for analysis of both experiments. Parasite
load was quantiﬁed as the maximum asexual para-
sitaemia. In Exp. 1, parasite and virulence data from
only the mice that experienced the full course of
infection were analysed. Maximum plasma cytokine
concentrations were analysed for all mice in that
experiment. In Exp. 2, parasitaemia and anaemia
observed after the cessation of treatment (days 9
through 16 p.i. inclusive) were also analysed and
are referred to as the average post-treatment RBC
count or parasitaemia. Finally, immunological data
from Exp. 2 (day 7 plasma cytokine concentrations)
were analysed. Prior to statistical analysis, it was
necessary to transform the data to meet the necessary
normality and homogeneity-of-variances assump-
tions (Grafen and Hails, 2002). Box-Cox transfor-
mations were carried out on all non-normal data as
an exploratory tool to help determine the optimal
transformation required for normalization. InExp. 1,
all cytokine and RBC density data were log10 trans-
formed prior to analysis, whereas in Exp. 2, the
weight, IL-12p70 and IFN-c data were square
root transformed, the parasitaemia, IL-6 and IL-10
data were natural log transformed and the RBC
parameters were inverse square root transformed.
Wherever possible, data are presented in their
original units for intuitive ease.
All traits mentioned above were analysed using
Analysis of Variance (ANOVAs) or Covariance
(ANCOVAs) in MINITAB (release 14, MINITAB
Inc.). Explanatory variables for clone, treatment
and an interaction between those terms were ﬁtted
to the data. Clone had up to 5 factor levels (CW,
AS, BC, AJ and Naı¨ve) depending on the analysis,
and in Exp. 2, treatment had 2 factor levels
(huIgG1 and TNFR-Ig). For all models, we ﬁrst
ﬁtted the maximal model including covariate when
relevant, and minimal models were obtained by
removing non-signiﬁcant terms (P-value >0.05).
We report F values, the test statistic for ANOVA,
as well as P values for full statistical disclosure
(Olsen, 2003). Naı¨ve (uninfected) mice suﬀered
signiﬁcantly less virulence and induced signiﬁ-
cantly lower cytokine titres relative to infected mice
groups regardless of clone, and so were removed
from the analyses. To control for the role parasite
load may play in determining virulence, a separate
analysis was carried out which included maximum
parasitaemia as a covariate. Finally, we tested
the directional hypothesis that clone virulence
increases with increasing pro-inﬂammatory re-
sponse (TNF-a or IFN-c :IL-10) using an ordered
heterogeneity test (Rice and Gaines, 1994). The
OH test combines the P value from the appropriate
ANOVA (Pc) with the Spearman’s rank correlation
coeﬃcient (rs) to calculate the test statistic (rsPc)
as follows: rsPc=rr (1xP) (Rice and Gaines,
1994).
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RESULTS
Experiment 1: clone-speciﬁc induction of TNF-a.
Wild type C57BL/6 female hosts were infected with
106 parasites of 1 of 4 genetically distinct P.c.c.
clones; denoted CW, AS, BC and AJ. One mouse
died during the experiment and was removed from
the analyses (AJ infected mouse on day 13 p.i.). The
course of these distinct primary infections, including
the virulence and cytokine responses they induced,
were examined. Maximum asexual parasitaemias
did not diﬀer signiﬁcantly between clones (Fig. 1A;
clone: F3,8=1.7, P>0.05). However, clone diﬀer-
ences in virulence were found, with clones AJ and
BC inducing lower minimum weight and RBC
densities than CW or AS infections (Fig. 1B;
clone: F3,7=11, P<0.01; and Fig. 1C; clone:
F3,8=6, P<0.05, respectively). These clone diﬀer-
ences in weight and RBC loss agree with previous
studies (Mackinnon and Read, 1999a, b, 2004) and
were maintained even when controlling for parasite
load (clone: F3,6=10, P<0.01; and clone: F3,7=10,
P<0.01, respectively). Hence, the virulence diﬀer-
ences observed between clones are not simply a
consequence of parasite burden.
Clones diﬀered in the cytokine proﬁle they in-
duced over time, with signiﬁcant clone diﬀerences
in day 5 IFN-c levels, as well as day 7 TNF-a and
IL-6 levels (Fig. 2A; clone: F3,8=14, P<0.001;
Fig. 2B; clone: F3,8=5.4, P<0.05 and Fig. 2C;
clone: F3,8=7.2, P<0.05). The most virulent clones,
AJ and BC, induced high concentrations of pro-
inﬂammatory cytokines: both induced TNF-a ;
BC also induced IFN-c, while AJ induced IL-6
(Fig. 2A,B and C). A trend was observed whereby
IL-10 levels were elevated during infection with
avirulent clones on day 5 p.i., but this was not
signiﬁcant (Fig. 2D; clone: F3,8=1.2, P<0.4).
Although clone diﬀerences in plasma cytokine pro-
ﬁles were found, only the amount of TNF-a induced
on day 7 p.i. correlated with clone diﬀerences in
virulence (Fig. 2A; clone: F3,8=5, P<0.05, rsPc=
0.97, P<0.01; and controlling for average para-
sitaemia; clone: F3,7=6, P<0.05, rsPc=0.97, P<
0.01). Thus, it is possible that clone diﬀerences in
TNF-a induction around the peak of parasitaemia
can help explain clone diﬀerences in virulence that
are not accounted for by parasite load.
Experiment 2: eﬀect of blocking TNFR1 signalling
during genetically distinct malaria infections
TNFR1 signalling was blocked via the adminis-
tration of a soluble TNF receptor 1 fusion protein
(TNFR-Ig) during each of four distinct P.c.c. in-
fections (as above) and in vivo virulence, parasite
dynamics and host plasma cytokine response were
followed throughout infection. Three mice died
during the experiment and were removed from our
analyses (2 IgG-treated, AJ-infected mice and 1
TNFR-Ig-treated, BC-infected mouse on days 10
and 11 p.i.).
(i)Virulence. In vivo blocking of TNFR1 signalling
protected mice against malaria-induced weight
loss (Fig. 3A,B; treatment: F1,28=7, P<0.01). As
observed above, clone diﬀerences in weight loss
were found (Fig. 3B; clone:F3,28=13,P<0.001), but
the level of protection conferred by treatment did
not vary among clones (Fig. 3B; clonertreatment:
F3,28=2, P=0.2). For example, the protection from
weight loss the TNFR-Ig treatment aﬀorded to
AS infected mice did not diﬀer signiﬁcantly from
that aﬀorded to AJ infected mice, even though the
latter lost almost 2 g more weight. Although clone
Fig. 1. Eﬀect of Plasmodium chabaudi parasite clone on
the kinetics of asexual parasitaemia (A), minimum weight
(B) and minimum RBC density (C) reached during
genetically distinct single-clone infections. Infections
were initiated with 106 RBCs parasitized with 1 of P.c.c.
clones CW, AS, BC or AJ. Parasitaemia and virulence
measurements were collected every day. Mice were
sacriﬁced on days 2, 5, 7 and 14 p.i. Each line
represents the mean of 12, 9, 6 and 3 mice up to these
time-points, respectively (+/xS.E.) (A) and each bar
represents the least square mean of 3 mice (+/xS.E.)
(B and C).
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diﬀerences in post-treatment anaemia were found
(Fig. 3C andD; clone:F3,28=3,P<0.05), in contrast
to weight loss, blocking TNFR1 signalling did
not aﬀect the degree of anaemia induced (Fig. 3D;
treatment and clonertreatment: P>0.05 in all
cases). Thus, blocking TNFR1 signalling protects
against malaria-induced weight loss, but the extent
of this protection does not vary among clones. In
addition, blockingTNFR1 signalling has no eﬀect on
the anaemia induced by any of the clones.
(ii) Parasite load. For the ﬁrst 8 days of infection,
treatment did not signiﬁcantly aﬀect asexual para-
site dynamics (Fig. 4A). However, after treatment
stopped on day 9 p.i., depleted mice suﬀered
elevated parasitaemias (Fig. 4A and B; average
post-treatment parasitaemia; treatment: F1,29=7,
P<0.05). We analysed several aspects of the parasite
data presented in Fig. 4A. While there were clone
diﬀerences in average parasitaemia and day of peak
parasitaemia (Fig. 4A; clone: F3,29=5, P<0.01; and
clone: F3,29=10, P<0.001, respectively) and near
signiﬁcant diﬀerences in both the maximum and
average post-treatment parasitaemia (clone:F3,29=2,
P=0.09; and clone: F3,29=3, P=0.06, respectively),
the magnitude of these clone diﬀerences was un-
aﬀected by treatment (clonertreatment: P>0.05 in
all cases). Thus, blocking TNFR1 signalling had
similarly negligible eﬀects on parasite kinetics for
all the clones.
(iii)Per-parasite virulence. Todiﬀerentiate between
the roles that parasite load and immunopathology
play in driving malaria virulence (Graham et al.
2005) we examined the eﬀects of clone and treatment
on virulence by statistically taking maximum para-
sitaemia into account. Although parasite load was
a signiﬁcant predictor of weight loss (F1,27=8,
P<0.01), it did not aﬀect clone diﬀerences in weight
loss, nor the protective eﬀect of treatment on
minimum weight (clone: F3,27=10, P<0.001, treat-
ment: F1,27=7, P<0.05, clonertreatment: F3,27=2,
P=0.1). These results show that TNFR-1 signalling
contributes towards malaria-induced weight loss,
independently of parasite load or parasite genotype.
Thus, the virulence diﬀerences among clones and
treatments depicted in Fig. 3B and D are not due to
parasitaemia diﬀerences alone.
For a given parasite burden, TNFR-Ig treated
mice suﬀered greater anaemia from day 9 p.i. on-
wards after treatment ended (treatment: F1,27=5,
P<0.05). In contrast, clone diﬀerences in post-
treatment anaemia were removed once parasite
load was taken into account (clone: F3,27=2, P=0.2
and clonertreatment: F3,27=0.4, P=0.8). Parasite
load alone thus explains clone diﬀerences in post-
treatment anaemia.
(iv) Cytokines associated with immunopathology. To
examine the induction of cytokines that might
contribute to the clone or treatment eﬀects on
virulence, we measured the levels of several plasma
cytokines on day 7 p.i. during Exp. 2. Clones diﬀered
signiﬁcantly in the induction of plasma IFN-c,
IL-6 and IL-10 on day 7 p.i. (Table 1). Treatment,
on the other hand, only signiﬁcantly aﬀected plasma
IL-6, with TNFR-1 blockade causing elevated
Fig. 2. Eﬀect of Plasmodium chabaudi parasite clone
(CW, AS, BC or AJ) on the levels of plasma TNF-a (A),
IFN-c (B), IL-6 (C) and IL-10 (D). Single-clone P.c.c.
infections were initiated and blood was obtained from
individual mice on the day of sacriﬁce (days 2, 5 and
7 p.i.). Plasma cytokine levels were determined using a
ﬂow cytometric cytokine bead array (see Materials and
Methods section). Each bar represents the mean of
3 mice (+/xS.E.).
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Fig. 3. For legend see opposite page.
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IL-6 levels on day 7 p.i., regardless of P.c.c. clone
(Table 1).
We are interested in whether clone virulence
or avirulence relates to the development of pro- or
anti-inﬂammatory cytokine responses. In this regard,
we found that controlling for parasite load, day 7
plasma IFN-c levels helped to explain both
the minimum live-weight and anaemia reached
(F1,26=21, P<0.001 and F1,26=8, P<0.01, respect-
ively). Just as we investigated the role that parasite
loadplays in driving virulence in the previous section,
wenowobserve that our virulence results (Fig. 3B,D)
relate to IFN-c levels. Thus, elevated IFN-c around
the peak of infection may have detrimental virulence
outcomes (Kremsner et al. 1992; Waki et al. 1992).
High ratios of pro- to anti-inﬂammatory cytokines
have been associated with malaria virulence in the
ﬁeld (Dodoo et al. 2002). In agreement with this, our
data show that the ratio of IFN-c to IL-10 is higher
for more virulent P.c.c. infections, regardless of
parasite load (Fig. 5; clone: F3,28=3.2, P<0.05;
and clone: rsPc=0.966, P<0.01). Thus, it is poss-
ible that clone diﬀerences in IFN-c induction,
or in the regulation of IFN-c by anti-inﬂammatory
cytokines, contribute towards clone diﬀerences in
malaria virulence.
DISCUSSION
Malaria virulence may be induced directly by
the parasite or via immune-mediated mechanisms,
which include TNF-a ( Grau et al. 1987; Clark and
Fig. 3. Eﬀect of parasite clone and TNFR-Ig treatment on the kinetics of malaria-induced weight and red blood cell
loss. Daily or every other day, mice were weighed and red blood cell counts obtained. Changes in live-weight over time
(A), minimum live-weight (B), kinetics of RBC density over time (C), and minimum RBC density (D) during the
course of primary infection with 1 of 4 P.c.c. clones (CW, AS, BC or AJ) are shown for TNFR-Ig treated mice (open
symbols and hatched bars) or control IgG-treated mice (solid symbols and solid bars). Each line or bar represents the
mean of 5 mice (+/xS.E.), except where deaths occurred as noted in the Results section.
Fig. 4. Eﬀect of parasite clone and TNFR-Ig treatment on the kinetics of asexual parasitaemia. Plots represent the
percentage parasitized RBCs during infection with 1 of 4 P.c.c. clones (CW, AS, BC or AJ) in TNFR-Ig-treated mice
(open symbols and hatched bars) or control IgG-treated mice (solid symbols and ﬁlled bars) (A). Bars represent the
least square mean of post-treatment asexual parasitaemia (days 9–16 inclusive), broken down by clone and treatment
(B). Each line or bar represents the mean of 5 mice (+/xS.E.), except where deaths occurred as noted in the Results
section.
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Chaudhri, 1988a, b ; Kern et al. 1992). For example,
high levels of serum TNF-a correlate with poor
outcome and disease severity in both rodent (Clark
and Chaudhri, 1988a, b) and human (Kwiatkowski,
1990; Kwiatkowski et al. 1990) malaria infections.
We hypothesized that P.c.c. clones may achieve high
virulence by (i) growing to high parasite densities,
(ii) inducing an exacerbated TNF-a response, or
(iii) via a combination of these factors.
In Exp. 1, we observed that more virulent malaria
clones induced higher day 7 plasma TNF-a levels,
even when parasite load was taken into account.
In Exp. 2, TNFR1 signalling was blocked during
genetically distinct infections, with the expectation
that clone virulence schedules would be diﬀerentially
aﬀected and possibly eliminated. However, we
found that regardless of parasite genotype, blocking
TNFR-1 signalling ameliorated weight loss, and had
little eﬀect on anaemia or parasitaemia. These data
suggest that the contribution of TNF-a to malaria
virulence does not depend on P.c.c. genotype. Thus,
the previously reported eﬀects of TNF-a on both
the virulence and parasitaemia during P.c.c. AS
infections (Jacobs et al. 1996; Li and Langhorne,
2000; Sam et al. 1999) appear representative of
those observed across the suite of P.c.c. clones we
studied.
Separating the pathogenic eﬀects of an overzealous
immune response from those of parasite burden is
extremely diﬃcult (Graham et al. 2005). By adding
parasitaemia to statistical models, we were able
to show that clone diﬀerences in the induction of
plasma TNF-a on day 7 p.i. are not completely
driven by parasite load and correlate with virulence.
In the same respect, lethal and non-lethal P. yoelii
infections have been shown to diﬀer in their ability
to induce early TGF-b, despite no signiﬁcant dif-
ferences in parasite load at that time (Omer et al.
Table 1. Eﬀects of TNFR1 blockade and Plasmodium chabaudi clone on levels of plasma IL-6, IFN-c,
IL-10 and IL-12p70 on day 7 post-infection
Plasma cytokine concentration (pg/ml)a
Clone Treatment IL-6c IFN-c IL-10 IL-12p70
CW
huIgG1 47.5¡1 5.3¡0.5 12.9¡1.9 31.7¡1.5
TNFR-Ig 151.4¡9.2 7.6¡0.3 14.4¡1.0 32.8¡1.3
AS
huIgG1 70.1¡8.4 46.3¡4.8 33.0¡5.3 29.0¡3.6
TNFR-Ig 155.9¡19.3 43.2¡0.9 55.4¡7.7 56.5¡2.9
BC
huIgG1 111.2¡9.1 57.1¡3.1 0d 20.5¡2.3
TNFR-Ig 90.6¡8.2 28.8¡1.4 15.2¡2.4 39.7¡2.6
AJ
huIgG1 20.9¡1.7 13.8¡1.2 16.6¡2.6 34.0¡3.7
TNFR-Ig 55.2¡3.2 25.6¡1.1 25.7¡2.7 33.4¡1.0
signiﬁcance of clone
diﬀerencesb
F3,29=3 F3,29=5 F3,29=3 ns
P<0.05 P<0.01 P<0.05
a Mice were infected with 106 pRBCs of 1 of 4 P.c.c. clones (CW, AS, BC or AJ), blood was obtained from individual
mice on day 7 p.i., and plasma levels of IL-6, IFN-c, IL-10 and IL-12 p70 were determined. Data are the mean of 5 mice
(¡S.E.), per clone per treatment, except where deaths occurred as noted in the Results section.
b Eﬀects of clone on levels of plasma cytokines was investigated via ANOVA and signiﬁcance tests are indicated. ns, Not
signiﬁcant.
c TNFR-Ig-treated mice had signiﬁcantly higher IL-6 levels compared to control huIgG1 mice (F1,29=5, P<0.05),
regardless of clone.
d 0, values below detection limits of assay.
Fig. 5. Eﬀect of parasite clone on the ratio of plasma
IFN-c to IL-10 on day 7 post-infection, for each of 4
P.c.c. clones (CW, AS, BC or AJ). Blood was obtained
from individual mice on day 7 p.i. and plasma levels of
IFN-c and IL-10 were determined. The natural log
transformation was applied to data to meet the necessary
homogeneity-of-variance and normality assumptions.
Bars are least square mean of 5 mice per infecting clone
(¡S.E.), except where deaths occurred as noted in the
Results section.
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2003). Furthermore, the enhanced disease severity
of IL-10-deﬁcient mice infected with the parasites
Trypanosoma cruzi (Hunter et al. 1997), Toxoplasma
gondii (Gazzinelli et al. 1996), Helicobacter hepaticus
(Kullberg et al. 1998) or P. chabaudi (Li et al. 1999)
did not correlate with increased parasite burdens, but
rather with an increased inﬂammatory response.
These data suggest that for many parasite species,
disease severity is at least partly immune mediated
and independent of parasite load.
There are several possible mechanisms by which
diﬀerent malaria genotypes might induce TNF-a,
independent of parasite burden. For example, it is
plausible that the cellular source of TNF-a, or
alternatively the trigger for TNF-a release, may
diﬀer during infections with genetically distinct
parasites. It has been shown that during P.c.c AS
infections, macrophages (Stevenson et al. 1992)
and dendritic cells (Seixas et al. 2001) can produce
TNF-a upon direct stimulation by the parasite
in vitro, and CD4+ T cells have also been shown
to produce TNF-a during malaria infection
(Hirunpetcharat et al. 1999). If P.c.c. clones diﬀer in
ability to induce these cellular responses, this could
explain the diﬀerential ampliﬁcation of TNF-a
we observe in the plasma. It would be of interest to
determine what the cellular source(s) of cytokines
are during infection with our distinct clones, and
also to examine whether clones diﬀer in antigenicity.
A substantial amount is currently known regard-
ing P.c.c. AS immunology (Langhorne et al. 2004;
Stevenson and Riley, 2004), but all other P.c.c.
clones await similar attention.
Our data suggest that TNFR1 signalling is dis-
pensable (between days 5 and 8 p.i.) for the ultimate
control of malaria infection, regardless of parasite
genotype. To our knowledge, the reagents used in
this study do not distinguish between TNF-a and
the closely related cytokine, lymphotoxin-a (LT-a),
which can both signal through TNFR1 and thus
we have been cautious to attribute treatment eﬀects
to TNFR1 signalling rather than TNF-a itself. In
any case, cytokine redundancies may help explain
the relatively small eﬀects of TNFR-Ig treatment.
For example, IL-6 or IFN-c could be compensating
for the absence of TNFR1 signalling. It has been
proposed that diﬀerences in induction of key anti-
inﬂammatory cytokines, which act to down-regulate
the nascent pro-inﬂammatory response, may also
contribute to malaria pathology (Dodoo et al. 2002;
Artavanis-Tsakonas et al. 2003). In this regard we
found that ratios of plasma IFN-c to IL-10 correlate
with clone virulence. Future experiments designed
to block other key cytokines (including IL-6 and
IFN-c), possibly in combination, during diverse
malaria infections may reveal cytokines that diﬀer-
entially aﬀect clone virulence. Finally, it is possible
that TNFR-independent pathways for virulence
determination exist, for example both the induction
of nitric oxide (NO), and generation of reactive
oxygen species have been implicated in the patho-
genesis of severe malaria (Clark et al. 1983; Anstey
et al. 1996; Griﬃths et al. 2001), and may contribute
to the clone virulence diﬀerences observed.
In conclusion, our results demonstrate that
blocking TNFR1 signalling protects against weight
loss during P.c.c. infections, regardless of parasite
genotype or parasitaemia. However, a role for para-
site genotype in determining the contribution of
IFN-c and IL-6-mediated pathology to virulence
is not ruled out by this study. Hence, studies
aimed at investigating the contribution of cytokine-
mediated pathways to the virulence induced by
genetically diverse malaria infections deserve fur-
ther attention. Clearer deﬁnition of the root causes
of malarial virulence, including the proportion due
to immunopathology, would help to identify essen-
tial targets which could be used in the treatment
of malaria.
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